中外製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/10/21 | 7,010 | 7,059 | 6,921 | 7,003 | -19 | -0.3% | 1,122,900 |
| 2024/10/18 | 7,104 | 7,141 | 6,981 | 7,022 | -20 | -0.3% | 1,176,800 |
| 2024/10/17 | 7,231 | 7,231 | 7,038 | 7,042 | -119 | -1.7% | 2,014,900 |
| 2024/10/16 | 7,342 | 7,371 | 7,159 | 7,161 | -296 | -4% | 2,633,800 |
| 2024/10/15 | 7,446 | 7,652 | 7,428 | 7,457 | +352 | +5% | 3,600,800 |
| 2024/10/11 | 7,049 | 7,192 | 7,028 | 7,105 | +156 | +2.2% | 2,882,800 |
| 2024/10/10 | 7,028 | 7,065 | 6,931 | 6,949 | -79 | -1.1% | 1,321,600 |
| 2024/10/09 | 6,985 | 7,043 | 6,943 | 7,028 | +133 | +1.9% | 1,165,300 |
| 2024/10/08 | 6,808 | 6,897 | 6,784 | 6,895 | -13 | -0.2% | 2,018,400 |
| 2024/10/07 | 6,961 | 7,055 | 6,854 | 6,908 | -7 | -0.1% | 2,378,600 |
| 2024/10/04 | 6,900 | 7,068 | 6,897 | 6,915 | -65 | -0.9% | 1,752,700 |
| 2024/10/03 | 7,051 | 7,078 | 6,932 | 6,980 | +129 | +1.9% | 1,609,700 |
| 2024/10/02 | 7,052 | 7,085 | 6,771 | 6,851 | -223 | -3.2% | 2,730,200 |
| 2024/10/01 | 6,970 | 7,116 | 6,941 | 7,074 | +142 | +2% | 1,803,200 |
| 2024/09/30 | 6,889 | 7,056 | 6,880 | 6,932 | -407 | -5.5% | 3,733,200 |
| 2024/09/27 | 7,212 | 7,339 | 7,097 | 7,339 | +197 | +2.8% | 2,794,500 |
| 2024/09/26 | 6,965 | 7,177 | 6,862 | 7,142 | +142 | +2% | 3,812,200 |
| 2024/09/25 | 7,125 | 7,248 | 6,950 | 7,000 | -96 | -1.4% | 2,362,600 |
| 2024/09/24 | 6,884 | 7,100 | 6,866 | 7,096 | +247 | +3.6% | 3,119,700 |
| 2024/09/20 | 6,888 | 6,946 | 6,849 | 6,849 | +41 | +0.6% | 2,275,900 |
| 2024/09/19 | 6,879 | 6,911 | 6,782 | 6,808 | +54 | +0.8% | 1,715,000 |
| 2024/09/18 | 6,832 | 6,866 | 6,665 | 6,754 | -113 | -1.6% | 1,928,600 |
| 2024/09/17 | 6,790 | 6,898 | 6,778 | 6,867 | +147 | +2.2% | 2,637,300 |
| 2024/09/13 | 6,732 | 6,820 | 6,686 | 6,720 | -112 | -1.6% | 3,749,000 |
| 2024/09/12 | 6,680 | 6,883 | 6,630 | 6,832 | +352 | +5.4% | 2,679,100 |
| 2024/09/11 | 6,585 | 6,639 | 6,441 | 6,480 | -104 | -1.6% | 1,924,800 |
| 2024/09/10 | 6,533 | 6,710 | 6,484 | 6,584 | +37 | +0.6% | 2,099,100 |
| 2024/09/09 | 6,477 | 6,573 | 6,396 | 6,547 | -30 | -0.5% | 1,773,800 |
| 2024/09/06 | 6,625 | 6,763 | 6,577 | 6,577 | -48 | -0.7% | 2,131,300 |
| 2024/09/05 | 6,850 | 6,882 | 6,612 | 6,625 | -318 | -4.6% | 2,050,900 |
| 2024/09/04 | 6,889 | 7,012 | 6,810 | 6,943 | -174 | -2.4% | 2,384,100 |
| 2024/09/03 | 6,995 | 7,117 | 6,957 | 7,117 | +181 | +2.6% | 1,866,900 |
| 2024/09/02 | 7,281 | 7,346 | 6,865 | 6,936 | -448 | -6.1% | 2,663,900 |
| 2024/08/30 | 7,400 | 7,485 | 7,270 | 7,384 | +1 | ±0% | 2,387,600 |
| 2024/08/29 | 7,335 | 7,428 | 7,285 | 7,383 | +48 | +0.7% | 1,495,600 |
| 2024/08/28 | 7,358 | 7,410 | 7,220 | 7,335 | -1 | ±0% | 1,584,400 |
| 2024/08/27 | 7,150 | 7,359 | 7,135 | 7,336 | +237 | +3.3% | 2,053,500 |
| 2024/08/26 | 7,070 | 7,143 | 6,859 | 7,099 | -121 | -1.7% | 2,184,600 |
| 2024/08/23 | 7,200 | 7,377 | 7,135 | 7,220 | +106 | +1.5% | 3,058,800 |
| 2024/08/22 | 7,000 | 7,248 | 6,980 | 7,114 | +266 | +3.9% | 3,451,500 |
| 2024/08/21 | 6,876 | 7,000 | 6,843 | 6,848 | -85 | -1.2% | 1,725,900 |
| 2024/08/20 | 6,759 | 6,985 | 6,680 | 6,933 | +147 | +2.2% | 2,406,100 |
| 2024/08/19 | 6,819 | 6,886 | 6,696 | 6,786 | -74 | -1.1% | 2,051,900 |
| 2024/08/16 | 6,684 | 6,888 | 6,663 | 6,860 | +272 | +4.1% | 2,930,900 |
| 2024/08/15 | 6,460 | 6,628 | 6,441 | 6,588 | +210 | +3.3% | 2,775,000 |
| 2024/08/14 | 6,321 | 6,399 | 6,260 | 6,378 | +139 | +2.2% | 2,137,700 |
| 2024/08/13 | 6,118 | 6,284 | 6,114 | 6,239 | +117 | +1.9% | 2,384,700 |
| 2024/08/09 | 6,129 | 6,294 | 6,057 | 6,122 | +155 | +2.6% | 3,771,400 |
| 2024/08/08 | 5,900 | 6,118 | 5,823 | 5,967 | -205 | -3.3% | 2,832,200 |
| 2024/08/07 | 5,866 | 6,443 | 5,853 | 6,172 | +125 | +2.1% | 4,158,100 |
151～
200
件表示中 / 3713件
類似銘柄と比較する
現在ご覧いただいている「中外薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 中外薬 | 735,600円 | +1.7% | +5.0% | 3.40% | 29.53倍 | 6.37倍 |
|
ロシュ傘下で成長続ける異色の医薬品大手。抗体・バイオで先行、抗がん剤、骨・関節領域に強い |
| 第一三共 | 359,200円 | +6.0% | +4.0% | 2.17% | 22.30倍 | 4.12倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
| 武 田 | 427,000円 | -1.1% | +75.3% | 4.68% | 29.25倍 | 0.96倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位１０強入り |
| 大塚ＨＤ | 689,600円 | +2.2% | +10.2% | 1.74% | 13.24倍 | 1.33倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界９０カ所に工場 |
| アステラス薬 | 139,000円 | +0.9% | +380.2% | 5.61% | 19.14倍 | 1.64倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
市場注目の銘柄
チャート関連のコラム
